FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1502461041> ?p ?o ?g. }

• W1502461041 endingPage "4306" @default.
• W1502461041 startingPage "4295" @default.
• W1502461041 abstract "Numerous studies have suggested that iron (Fe) chelators such as desferrioxamine (DFO) may be useful antitumor agents (Blatt and Stitely, Cancer Res 47:1749, 1987; Becton and Bryles, Cancer Res 48:7189, 1988). Recent work with several analogues of the lipophilic Fe chelator, pyridoxal isonicotinoyl hydrazone (PIH), indicate that some of these ligands are considerably more efficient than DFO both in terms of their Fe chelation efficacy and at preventing 3H-thymidine incorporation by neuroblastoma (NB) cells (Richardson and Ponka, J Lab Clin Med 124:660, 1994). Considering this fact, the present study was designed to test the antiproliferative effect of a wide range of PIH analogues to identify the most active compounds. A total of 36 ligands have been examined that were synthesized by condensation of three types of aromatic aldehydes (pyridoxal, salicylaldehyde, and 2-hydroxy-1- naphthyladehyde) with a range of acid hydrazides. The effects of these chelators were assessed using the human NB cell line, SK-N-MC. Although PIH was far more effective than DFO at preventing Fe uptake from transferrin, it was less effective than DFO at preventing cellular proliferation (DFO ID50 = 22 mumol/L; PIH ID50 = 75 mumol/L). In contrast, 14 PIH analogues were far more efficient than DFO at preventing proliferation (ID50 = 1 to 7 mumol/L) and may have potential as antitumor agents. The most effective compounds were those hydrazones derived from 2-hydroxy-1-naphthylaldehyde. Most of the PIH analogues were considerably more effective than DFO at both preventing 59Fe uptake from 59Fe-transferrin and in mobilizing 59Fe from prelabeled NB cells. In addition, a linear relationship between Fe chelation efficacy and antiproliferative activity was found only for hydrazones derived from salicylaldehyde. Apart from gallium (Ga) nitrate having an antiproliferative effect by itself, this metal potentiated the antiproliferative effect of PIH but not that of DFO. Spectrophotometric studies showed that PIH could chelate Ga, and it can be suggested that, like the PIH-Fe complex that donates Fe to reticulocytes (Ponka et al, Biochim Biophys Acta 718:151, 1982), the PIH-Ga complex may efficiently bestow Ga to NB cells. The results suggest that analogues of PIH deserve further vigorous investigation because they may be useful therapeutic agents for the treatment of cancer." @default.
• W1502461041 created "2016-06-24" @default.
• W1502461041 creator A5017905338 @default.
• W1502461041 creator A5025060892 @default.
• W1502461041 creator A5056211046 @default.
• W1502461041 date "1995-12-01" @default.
• W1502461041 modified "2023-10-12" @default.
• W1502461041 title "The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents" @default.
• W1502461041 cites W128791626 @default.
• W1502461041 cites W1497514444 @default.
• W1502461041 cites W1554150268 @default.
• W1502461041 cites W1564880933 @default.
• W1502461041 cites W1571406674 @default.
• W1502461041 cites W1575773639 @default.
• W1502461041 cites W1584681190 @default.
• W1502461041 cites W1603151752 @default.
• W1502461041 cites W1649488331 @default.
• W1502461041 cites W1652008074 @default.
• W1502461041 cites W1780644854 @default.
• W1502461041 cites W1871616831 @default.
• W1502461041 cites W1967102030 @default.
• W1502461041 cites W1968853836 @default.
• W1502461041 cites W1970518172 @default.
• W1502461041 cites W1976770725 @default.
• W1502461041 cites W1983842085 @default.
• W1502461041 cites W1992125101 @default.
• W1502461041 cites W1992895997 @default.
• W1502461041 cites W2012108057 @default.
• W1502461041 cites W2012851809 @default.
• W1502461041 cites W2025177304 @default.
• W1502461041 cites W2025984741 @default.
• W1502461041 cites W2034409947 @default.
• W1502461041 cites W2047768402 @default.
• W1502461041 cites W2051983330 @default.
• W1502461041 cites W2052008210 @default.
• W1502461041 cites W2054170541 @default.
• W1502461041 cites W2054526986 @default.
• W1502461041 cites W2054662394 @default.
• W1502461041 cites W2055882158 @default.
• W1502461041 cites W206492848 @default.
• W1502461041 cites W2066053565 @default.
• W1502461041 cites W2073915702 @default.
• W1502461041 cites W2080711791 @default.
• W1502461041 cites W2081610483 @default.
• W1502461041 cites W2084429638 @default.
• W1502461041 cites W2087487456 @default.
• W1502461041 cites W2094335678 @default.
• W1502461041 cites W2094416787 @default.
• W1502461041 cites W2096804213 @default.
• W1502461041 cites W2104434601 @default.
• W1502461041 cites W2114918609 @default.
• W1502461041 cites W2119272726 @default.
• W1502461041 cites W2122899892 @default.
• W1502461041 cites W2137343940 @default.
• W1502461041 cites W2140927361 @default.
• W1502461041 cites W2141897767 @default.
• W1502461041 cites W2143656505 @default.
• W1502461041 cites W2149397803 @default.
• W1502461041 cites W2155930643 @default.
• W1502461041 cites W2169013600 @default.
• W1502461041 cites W2170247657 @default.
• W1502461041 cites W2223245761 @default.
• W1502461041 cites W2324563126 @default.
• W1502461041 cites W2400973399 @default.
• W1502461041 cites W2410507629 @default.
• W1502461041 cites W2417365885 @default.
• W1502461041 cites W2749058363 @default.
• W1502461041 cites W334184796 @default.
• W1502461041 cites W1929856092 @default.
• W1502461041 cites W2412088187 @default.
• W1502461041 doi "https://doi.org/10.1182/blood.v86.11.4295.bloodjournal86114295" @default.
• W1502461041 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7492790" @default.
• W1502461041 hasPublicationYear "1995" @default.
• W1502461041 type Work @default.
• W1502461041 sameAs 1502461041 @default.
• W1502461041 citedByCount "319" @default.
• W1502461041 countsByYear W15024610412012 @default.
• W1502461041 countsByYear W15024610412013 @default.
• W1502461041 countsByYear W15024610412014 @default.
• W1502461041 countsByYear W15024610412015 @default.
• W1502461041 countsByYear W15024610412016 @default.
• W1502461041 countsByYear W15024610412017 @default.
• W1502461041 countsByYear W15024610412018 @default.
• W1502461041 countsByYear W15024610412019 @default.
• W1502461041 countsByYear W15024610412020 @default.
• W1502461041 countsByYear W15024610412021 @default.
• W1502461041 countsByYear W15024610412022 @default.
• W1502461041 countsByYear W15024610412023 @default.
• W1502461041 crossrefType "journal-article" @default.
• W1502461041 hasAuthorship W1502461041A5017905338 @default.
• W1502461041 hasAuthorship W1502461041A5025060892 @default.
• W1502461041 hasAuthorship W1502461041A5056211046 @default.
• W1502461041 hasBestOaLocation W15024610411 @default.
• W1502461041 hasConcept C178790620 @default.
• W1502461041 hasConcept C181199279 @default.
• W1502461041 hasConcept C185592680 @default.
• W1502461041 hasConcept C197404232 @default.
• W1502461041 hasConcept C2776672577 @default.

• next